GLP-1

Class of therapeutic medications and emerging pharmaceutical market

AI overview

Class of therapeutic medications and emerging pharmaceutical market

Latest news

healthAugust 3

Conexeu Sciences CEO Miles Harrison Speaks on GLP-1 Market Opportunities

Conexeu Sciences CEO Miles Harrison joined a fireside chat to discuss strategic developments and commercial potential within the rapidly expanding GLP-1 healthcare market.

Related people

Miles Harrison
Person
health🇺🇸 United States
Chief Executive Officer of Conexeu Sciences
2 mentionsAugust 3